Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

R&D Market Pulse: Microsoft Unveils New AI; Merck Halts Hep C Drug Development

By R&D Editors | October 2, 2017

The R&D Market Pulse Index for the week ending September 29, 2017 closed at 3,507.48 for the 25 companies included. The Index was up 1.24 percent (or 42.86 basis points) over the week ending September 22, 2017. Thirteen R&D Index companies gained value last week from 0.05 percent (GlaxoSmithKline) to 4.72 percent (Bayer AG). Twelve R&D Index companies lost value last week from -0.03 percent (IBM) to -2.23% (Volkswagen).

The U.S. GDP grew at an annualized rate of 3.1 percent in the second quarter, according to a report released by the Commerce Dept. last week. This rate is stronger than the previously expected 3.0% and marks the strongest growth in two years. Analysts expect the economy to grow at a rate between 2 percent and 3 percent in the third quarter and steady growth following.

The Wall Street Journal/Times Higher Education (THE) college rankings for 2017 were announced last week with Harvard, Columbia, MIT, Stanford and Duke taking the top five spots. The rankings assess colleges in outcomes, resources, engagement and environment. The top public school was UCLA which was ranked 25th behind 24 private schools. Only 21 public schools made it into the top 100 highest ranked colleges.

R&D Index member Microsoft last week announced a new artificial intelligence (AI) product aimed at competing with IBM’s (also an R&D Index member) Watson AI products for everyday  business needs. Microsoft’s product will be one of a series of customizable AI products running on the company’s Azure cloud-computing platform. While Watson products target specific industries, Microsoft claims its new AI products address fundamental business needs.

R&D Index member Merck announced last week that it was discontinuing development of its new hepatitis C treatment, citing questionable effectiveness and an abundance of existing treatments including its own Zepatier drug. Earlier this year, R&D Index member Johnson & Johnson also discontinued its development of a hepatitis C drug citing non-competitive results.

China announced last Thursday new rules for gradually escalating quotas for pure electric cars, plug-in hybrids and fuel cell vehicles by 2019, hoping to curb air pollution and increase a domestic green-car industry. Anticipating these moves, Ford, Renault-Nissan, Volkswagen and General Motors have all set up joint ventures with Chinese auto manufacturers, earlier this year. In a partial concession to foreign car manufacturers, China agreed to delay implementation of these new regulations until 2019, rather than 2018 with a minimum of 10 percent of a company’s production consisting of green-car products, which increases in following years.

R&D Index Week Ending September 29, 2017

  Ticker Exchange 2017 R&D billions$ 09/22/17 09/29/17 9/29/17 to 9/22/17 9/29/17 to 1/1/17
Amazon AMZN NASDAQ 17,774 955.10 961.35 0.65% 28.20%
Alphabet/Google GOOGL NASDAQ 15,845 943.26 973.72 3.23% 22.87%
Microsoft MSFT NASDAQ 13,987 74.41 74.49 0.11% 19.87%
Intel INTC NASDAQ 13,499 37.18 38.08 2.42% 4.99%
Apple AAPL NASDAQ 11,506 151.89 154.12 1.47% 33.07%
Volkswagen AG VLKAY OTC 11,260 34.57 33.80 -2.23% 17.85%
Roche Pharm RHHBY OTC 10,174 32.02 32.00 -0.06% 12.16%
Toyota TM NYSE 9,170 120.63 119.17 -1.21% 1.68%
Johnson & Johnson JNJ NYSE 9,060 131.39 130.01 -1.05% 12.85%
Novartis NVS NYSE 7,870 86.16 85.85 -0.36% 17.86%
General Motors GM NYSE 7,468 39.42 40.38 2.44% 15.90%
Pfizer PFE NYSE 7,288 35.96 35.70 -0.72% 9.91%
Bristol-Myers Squibb BMY NYSE 6,942 63.36 63.74 0.60% 9.07%
Cisco CSCO NASDAQ 6,827 33.37 33.63 0.78% 11.28%
Qualcomm QCOM NASDAQ 6,723 52.09 51.84 -0.48% -20.49%
Oracle ORCL NYSE 6,702 48.16 48.35 0.39% 25.75%
Honda HMC NYSE 6,519 29.91 29.56 -1.17% 1.27%
Astra Zeneca PLC AZN NYSE 6,363 33.95 33.88 -0.21% 24.01%
Merck & Co. MRK NYSE 5,759 65.13 64.03 -1.69% 8.77%
Daimler DDAIY OTC 5,084 66.60 67.47 1.31% -4.60%
Bayer AG BAYN XETRA 4,880 110.10 115.30 4.72% 16.31%
Sanofi SA SNY NYSE 4,755 50.34 49.79 -1.09% 23.12%
IBM IBM NYSE 4,628 145.13 145.08 -0.03% -12.60%
GlaxoSmithKline GSK NYSE 4,508 40.58 40.60 0.05% 5.43%
Eli Lilly Co LLY NYSE 4,489 83.91 85.54 1.94% 16.30%
Total     209,080 3,464.62 3,507.48 1.24% 17.61%
               
    Biopharmaceutical 732.90 736.44 0.48% 14.12%
    Automotive 291.13 290.38 -0.26% 3.47%
    ICT   1,485.49 1,519.31 2.28% 16.28%

About the R&D Market Pulse Index

R&D Magazine’s R&D Index is a weekly stock market summary of the top international companies involved in research and development. The top 25 industrial spenders of R&D in 2017 were selected based on the latest listings from Schonfeld & Associates’ June 2017 R&D Ratios & Budgets. These 25 companies include pharmaceutical (11 companies), automotive (5), ICT  (8) and conglomerate (1) organizations who invested a cumulative total of more than $209 billion in R&D in 2017, or approximately 10% of all the R&D spent in the world by government, industries and academia combined, according to R&D Magazine’s 2017 Global R&D Funding Forecast. The stock prices used in the R&D Index are tabulated from NASDAQ, NYSE, XETRA and OTC common stock prices (in U.S. dollars) for the companies selected at the close of stock trading business on the Friday preceding the publication of the R&D Index in R&D Magazine’s R&D Daily eNewsletter.

The companies used in the R&D Index include Amazon, Alphabet/Google, Microsoft, Intel, Apple, Volkswagen AG, Roche Pharma, Toyota, Johnson & Johnson, Novartis, General Motors, Pfizer, Bristol-Myers Squibb, Cisco, Qualcomm, Oracle, Honda Motor Company, Astra Zeneca plc, Merck & Company, Daimler, Bayer AG, Sanofi SA, IBM, GlaxoSmithKline and Eli Lilly Co. Stock prices are based on those stocks traded on the U.S. exchanges. R&D Index trends (in the stock prices) are just one indicator of the amount of capital available to these high-technology companies to invest in R&D and should not be implied to indicate the absolute value of R&D investments made by these organizations. The companies chosen for the R&D Index have very large sophisticated internal and global R&D organizations with each company investing between $4.5 and $17 billion annually on their R&D efforts.

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
7 major R&D developments this week: Tariff uncertainty persists, Pfizer sells campus, Scania acquires Northvolt unit
economic crisis stock chart falling down business global money bankruptcy concept
7 major R&D developments this week: Tariffs roil markets, MIT wins $12B contract, Siemens plans $5B acquisition
EL SEGUNDO, CA/USA - OCTOBER 13, 2014: Boeing manufactuing facility. Boeing manufactures and sells aircraft, rotorcraft, rockets and satellites. It is the second-largest defense contractor in the world.
8 major R&D moves this week: HHS cuts 10,000 jobs while Anthropic & DataBricks form $100M pact
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE